Medicamen Biotech Share Price

Medicamen Biotech Share Price

NSE: MEDICAMEQ
|
Pharmaceuticals
|
S Cap
₹ 270.25
+₹10.85 (4.18%)
1D
Last updated 04 Sep, 2026, 15:29 IST

Medicamen Biotech Share Price Today

As of 4 Sep 2026, Medicamen Biotech share price is ₹270.25. The stock opened at ₹262.00, compared to its previous close of ₹259.40. During today's trading session, Medicamen Biotech share price moved in the range of ₹260.65 to ₹276.80, with an average price of ₹268.73 for the day. Looking at its last 52-week, the stock has touched a low of ₹212.40 and a high of ₹447.65. On the performance front, Medicamen Biotech share price has declined by 9.80% over the last six months and is down 22.03% on a year-on-year basis.

₹260.65
4.18% up today
₹276.80
1D LOW
1D HIGH

Medicamen Biotech Returns Calculator

Circuit
L
H
₹207.55
₹311.25
52-week
L
H
₹212.40
₹447.65

About Medicamen Biotech

Medicamen Biotech Share Price
ISIN
INE646B01010
Sector Market Cap
₹ 353.11 Cr

Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider. The Company is principally engaged in generic finished dosage forms (FDF), Oncology formulations and research and development services to cater to the needs of the global pharmaceutical industry. The Company’s focus areas include antibiotics, hypertension, general pain management, cardiovascular, diabetics and oncology formulations. In cardiology, the Company is delivering effective treatments for heart-related conditions. Its CNS products address neurological disorders, while its diabetology solutions focus on advanced diabetes management. It also contributes to the global fight against malaria with its anti-malarial medications. Additionally, the Company offers essential vitamins, antibiotics for bacterial infections, and comprehensive pain management solutions. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, and others.

Medicamen Biotech Financial Highlights

  • Revenue: Medicamen Biotech reported revenue of ₹200.88 crore in FY26 vs ₹168.79 crore in FY25. It showed an increase of 19.01% on a yearly basis.
  • Operating Profit: Medicamen Biotech reported an operating profit of ₹11.98 crore in FY26 vs ₹9.88 crore in FY25. It showed an increase of 21.26% on a year-on-year basis.
  • Net Profit: Medicamen Biotech reported a net profit of ₹9.80 crore in FY26 vs ₹6.56 crore in FY25. It showed an increase of 49.39% on a yearly basis.

Medicamen Biotech Quarterly Result Highlights

  • Medicamen Biotech reported revenue of ₹48.76 crore in Jun 2026, compared with ₹62.39 crore in Mar 2026, representing a decrease of 21.85% on a quarter-on-quarter (QoQ) basis.
  • Medicamen Biotech reported an operating profit of ₹2.57 crore in Jun 2026, compared with ₹5.06 crore in Mar 2026, representing a decrease of 49.21% on a quarter-on-quarter (QoQ) basis.
  • Medicamen Biotech reported a profit of ₹1.85 crore in Jun 2026, compared with ₹4.45 crore in Mar 2026, reflecting a decrease of 58.43% on a QoQ basis.
  • The earnings per share (EPS) of Medicamen Biotech stood at ₹5.60 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
40.46%
FII
0.07%
Other DII
0.40%
Retail and other
59.07%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.06%
Dec 20250.02%
Mar 20260.10%
Jun 20260.07%
Mkt Cap Cr
353.11
P/E
35.18
P/B
1.28
ROE
3.50%
D/E
0.13
ROCE
4.79%
Div. Yield
0.38%
EPS(TTM)
6.94
Turnover
0.51
EV/EBITDA
16.50
Net Margin
0.00%
Op. Margin
0.00%
ROA
2.70%
Quick Ratio
0.00
Curr. Ratio
4.85
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Medicamen Biotec outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Medicamen Biotec appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Medicamen Biotec earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,56,833.0037.705.4713.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,45,426.0083.9114.6415.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,87,320.0086.8922.2825.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,13,217.0024.654.1818.59%0.3117.35%237.300.09%0.3335.38
Cipla1,12,212.0033.443.2611.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,01,155.0092.7719.0916.77%0.4016.14%97.200.11%0.6713.72
Lupin97,626.3017.594.3523.76%0.0424.88%659.000.84%0.57129.18
Mankind Pharma96,859.1046.845.9411.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,405.5030.282.5311.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma93,614.0025.232.479.25%0.1911.76%394.820.25%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Medicamen Biotech Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹162.55₹179.31₹140.87₹115.45
Other Income₹6.24₹2.33₹2.46₹1.72
Total Revenue₹168.79₹181.63₹143.33₹117.17
Total Expenses₹158.91₹168.56₹126.28₹99.07
Profit Before Tax₹9.88₹13.08₹17.05₹18.09
Tax₹3.32₹3.58₹2.32₹3.20
Profit After Tax₹6.56₹9.49₹14.73₹14.90
EPS - Basic₹5.60₹8.63₹11.64₹12.19
EPS - Diluted₹5.60₹8.63₹11.64₹12.19

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹6.56₹9.49₹14.73₹14.90
Income before WC changes₹19.44₹23.84₹25.61₹25.13
Change in Assets-₹17.53-₹21.45-₹29.22-₹30.20
Change in Liabilities-₹8.71-₹6.07₹0.44₹12.38
Change in WC-₹26.25-₹27.52-₹28.78-₹17.82
Cash flow from Operations-₹8.16-₹6.74-₹6.29₹4.11
Cash flow from Investing-₹1.40-₹5.56-₹5.88-₹8.47
Cash flow from Financing-₹1.47₹6.31₹29.13₹4.30
Total Cash Flow-₹11.03-₹5.99₹16.95-₹0.07
Cash (Start of the year)₹14.79₹20.78₹3.82₹3.89
Cash (End of the year)₹3.76₹14.79₹20.78₹3.82

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹132.60₹134.96₹115.15₹102.66
Current Assets₹164.55₹159.59₹163.36₹123.04
Total Assets₹297.15₹294.55₹278.52₹225.69
Current Liabilities₹78.16₹84.56₹82.57₹72.69
Net Current Asset₹86.39₹75.04₹80.79₹50.35
Non-Current Liabilities₹5.94₹3.01₹2.53₹6.53
Equity Capital₹213.05₹206.98₹193.41₹146.47
Total Equity & Liabilities₹297.15₹294.55₹278.52₹225.69

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹151.46₹172.39₹137.88₹115.45
Other Income₹6.23₹2.30₹2.46₹1.72
Total Revenue₹157.69₹174.69₹140.35₹117.17
Total Expenses₹144.91₹157.80₹123.01₹99.06
Profit Before Tax₹12.77₹16.89₹17.33₹18.10
Tax₹3.33₹3.59₹2.33₹3.20
Profit After Tax₹9.45₹13.30₹15.00₹14.91
EPS - Basic₹7.43₹10.50₹12.04₹12.20
EPS - Diluted₹7.43₹10.50₹12.04₹12.20

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹9.45₹13.30₹15.00₹14.91
Income before WC changes₹22.28₹27.56₹25.90₹25.14
Change in Assets-₹12.84-₹17.14-₹34.31-₹25.97
Change in Liabilities-₹10.73-₹7.60₹1.79₹8.84
Change in WC-₹23.57-₹24.74-₹32.52-₹17.13
Cash flow from Operations-₹2.63-₹0.25-₹3.50₹4.81
Cash flow from Investing-₹1.72-₹8.71-₹7.54-₹8.47
Cash flow from Financing-₹6.68₹3.14₹27.67₹4.39
Total Cash Flow-₹11.04-₹5.82₹16.63₹0.73
Cash (Start of the year)₹14.62₹20.44₹3.81₹3.08
Cash (End of the year)₹3.58₹14.62₹20.44₹3.81

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹139.68₹141.84₹118.81₹104.72
Current Assets₹153.51₹152.37₹157.97₹120.98
Total Assets₹293.19₹294.21₹276.78₹225.70
Current Liabilities₹72.58₹82.30₹80.46₹71.13
Net Current Asset₹80.93₹70.07₹77.51₹49.85
Non-Current Liabilities₹2.97₹2.71₹2.53₹6.53
Equity Capital₹217.64₹209.21₹193.80₹148.04
Total Equity & Liabilities₹293.19₹294.21₹276.78₹225.70
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
270.25
2
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 2
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
58.54
Neutral
ATR (14)
14.84
Neutral
STOCH(9,6)
66.78
Neutral
STOCH RSI (14)
81.13
Bearish
ADX(9)
23.9
Bearish
UO(9)
55.35
Neutral
ROC(12)
14.92
Bullish
WillR(14)
-30.63
Neutral
Period
Simple value
Exponential vaue
5D
260.48
258.28
10D
248.98
252.04
20D
241.87
246.39
50D
242.75
244.9
100D
250.03
255.73
Volume trend — traded volume by day
4 Sep1L
3 Sep0L
2 Sep0L
1 Sep1L
31 Aug1L
28 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Medicamen Biotech Share Price
Medicamen Biotech
Pharmaceuticals
Add Stock
Add Another

Medicamen Biotech Share Price FAQs

Medicamen Biotech share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837